We are a company with the span of national and international partners, concentrating on the development of GMP phytopharmaceutical manufactured products. Based on our values and beliefs we create an integrated supply chain. In accordance with local laws and regulations, we want to provide high quality and certified products to our customers worldwide.
We supply pharmacies with high-quality, certified phytopharmaceuticals. Our main focus lies on medical cannabis. A guideline for doctors and detailed information on products and orders can be found in the DocCheck area.
The potential of CBD – derived from fiber hemp varieties – has been highlighted in many scientific publications in recent years. Multiple other cannabis ingredients seem to affect the medical effect. With our license to grow EU certified fiber hemp for scientific purposes, we get to the bottom of current issues.
We develop CBD products according to all guidelines for the production of phytopharmaceuticals. We work with different companies and experts. The hemp used is produced according to GACP standards and further processed in gentle CO2 extraction at Europe's leading company for plant extraction. The further processing, packaging and shipment according to GMP and GDP guidelines.
Ken has been a successful serial entrepreneur building on 35 years of experience in multiple sectors. His experience in high level team sports along with numerous successful projects has influenced him to build strong teams reliant on passion, integrity and work ethic. His vision is unique in the medical cannabis sector with the concept of standardized production and dosage. Ken enjoys a strong rapport with regulatory organizations, scientists, thought leaders and numerous strategic partnerships worldwide. Ken has a proven track record, having already built ABcann Global from an idea to a company valued in excess of $400 million.
John is a visionary entrepreneur with extensive cannabis industry knowledge worldwide. Having founded Sens Media and the P3 collective while simultaneously acting as an advocate for medicinal cannabis, John has established himself as one of the premier thought leaders in the industry in Germany. Well-connected politically, John has taken his sharp analytical industry insight and collaborated with some of the top scientists and advocates in the world. John is not only an advocate, he is a patient. He understands the product, its possibilities and has a unique view of where medical cannabis can develop and prosper as an industry worldwide. John has extensive experience in management and operations, business development, event planning, marketing, as well as public relations and consulting
Dr. Silke Will
HEAD OF RESEARCH & QMB
Dr. Silke Will holds a PhD in plant nutrition. Since 2016 she is one of the first female researchers in Germany who hold a license to research cannabis sativa for scientific purposes on a pharmaceutical level. Throughout her career, she acquired a broad knowledge about the production of cannabis products. Here, her focus lies on achieving the highest quality standards while conserving natural resources. Their partners include various steak holder in the cannabis industry.
Dr. Eva Milz
Dr. Eva Milz studied medicine at the RWTH Aachen, University of Cologne and at the University of Stellenbosch, South Africa. She earned her PhD in the field of neurosurgery of the pituitary and specialized in psychiatry and psychotherapy. Currently Dr. Milz works as a medical consultant for several companies such as publicis in Cologne. She also works as a consultant for medical publications of Bertelsmann Springer Medizin online, Berlin. She successfully treated over 400 patients with cannabinoids in her practice for psychiatry and psychology in Berlin.